Genechem

GeneChem Inc. specializes in advanced enzyme engineering and biomaterials, leveraging artificial intelligence and biosynthesis to develop novel enzymatic solutions. Its technical approach enhances natural processes through next-generation enzyme platforms, creating specialized ingredients for pharmaceutical, food, nutrition, and cosmetic industries, addressing diverse market needs.

GeneChem's operational history demonstrates strong scientific advancement. Key milestones include achieving U.S. Self-Affirmed GRAS status for sialyllactose and developing Human Milk Oligosaccharides. In 2021, Soulbrain Holdings Co., Ltd. acquired GeneChem, integrating its specialized capabilities into a broader corporate structure, supporting technological evolution.

GeneChem's offerings serve manufacturers in pharmaceutical, food, nutrition, and cosmetic sectors. The company aims to apply enzyme power to benefit the world, unlocking new possibilities in life sciences. Its forward-looking vision emphasizes responsible innovation and scientific validation, expanding advanced biotechnology applications globally.